The Latest Breaking News from Zacks

Organogenesis (ORGO) shares rallied 5.3% in the last trading session to close at $5.19. This move can be attributable to notable volume with a higher number of shares being traded than in a typical session. This compares to the stock's 0.4% gain over the past four weeks.

Heightened volatility and uncertainty in the stock market triggered by decades-high inflation, the Russia-Ukraine conflict and Fed's aggressive tightening policy have compelled investors to search for consistent income. In this regard, nothing is better than dividend investing.

Celsion Corp (NASDAQ: CLSN) shares are trading lower Wednesday after the company announced a $7 million registered direct offering priced at-the-market under Nasdaq rules.

Celsion Corp (NASDAQ: CLSN) shares are trading higher Tuesday as traders circulate a Zacks Small-Cap Research note with a $37 valuation target on the stock.